Allozyne Receives New Round

  • Feed Type
  • Date
    12/23/2011
  • Company Name
    Allozyne
  • Mailing Address
    1600 Fairview Ave E Seattle, WA 98102
  • Company Description
    Allozyne, Inc., is a privately held biotechnology company focused on the development and manufacture of protein therapeutics. These technologies will enable the company to improve the efficacy of protein-based therapeutics.
  • Website
    http://www.allozyne.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Funding proceeds will be used to help the company move its multiple sclerosis drug into phase III clinical trials.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    MPM Capital
  • Venture Investor
    OVP Venture Partners

By posting a comment, you agree to our terms and conditions.